Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.

CONTEXT An instructive paradigm for investigating the relationship between brain serotonin function and major depressive disorder (MDD) is the response to tryptophan depletion (TD) induced by oral loading with all essential amino acids except the serotonin precursor tryptophan. OBJECTIVE To determine whether serotonin dysfunction represents a trait abnormality in MDD in the context of specific neural circuitry abnormalities involved in the pathogenesis of MDD. DESIGN Randomized double-blind crossover study. SETTING Outpatient clinic. PARTICIPANTS Twenty-seven medication-free patients with remitted MDD (18 women and 9 men; mean +/- SD age, 39.8 +/- 12.7 years) and 19 controls (10 women and 9 men; mean +/- SD age, 34.4 +/- 11.5 years). INTERVENTIONS We induced TD by administering capsules containing an amino acid mixture without tryptophan. Sham depletion used identical capsules containing hydrous lactose. Fluorodeoxyglucose F 18 positron emission tomography studies were performed 6 hours after TD. Magnetic resonance images were obtained for all participants. MAIN OUTCOME MEASURES Quantitative positron emission tomography of regional cerebral glucose utilization to study the neural effects of sham depletion and TD. Behavioral assessments used a modified (24-item) version of the Hamilton Depression Rating Scale. RESULTS Tryptophan depletion induced a transient return of depressive symptoms in patients with remitted MDD but not in controls (P<.001). Compared with sham depletion, TD was associated with an increase in regional cerebral glucose utilization in the orbitofrontal cortex, medial thalamus, anterior and posterior cingulate cortices, and ventral striatum in patients with remitted MDD but not in controls. CONCLUSION The pattern of TD-induced regional cerebral glucose utilization changes in patients with remitted MDD suggests that TD unmasks a disease-specific, serotonin system-related trait dysfunction and identifies a circuit that probably plays a key role in the pathogenesis of MDD.

[1]  C. McDougle,et al.  Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.

[2]  P. Cowen,et al.  Neuroendocrine responses to intravenous tryptophan in major depression. , 1987, Archives of general psychiatry.

[3]  Karl J. Friston,et al.  Neuroanatomical correlates of externally and internally generated human emotion. , 1997, The American journal of psychiatry.

[4]  M. Fava,et al.  Predictors of Mood Response to Acute Tryptophan Depletion: A Reanalysis , 2002, Neuropsychopharmacology.

[5]  V. Arango,et al.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.

[6]  D J Kupfer,et al.  Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. , 1991, Archives of general psychiatry.

[7]  R. Dolan,et al.  Neural Activation during Covert Processing of Positive Emotional Facial Expressions , 1996, NeuroImage.

[8]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[9]  R. Salomon,et al.  Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action , 1999, Biological Psychiatry.

[10]  B. Kjellman,et al.  Serotonergic‘vulnerability’ in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram‐responders , 1998, Acta psychiatrica Scandinavica.

[11]  H L Miller,et al.  Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. , 1997, Archives of general psychiatry.

[12]  M E Phelps,et al.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. , 2001, Archives of general psychiatry.

[13]  M. Raichle,et al.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism , 2002, European Neuropsychopharmacology.

[14]  F. Hyder,et al.  Stimulated changes in localized cerebral energy consumption under anesthesia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Joseph E LeDoux,et al.  Serotonin Modulation of Sensory Inputs to the Lateral Amygdala: Dependency on Corticosterone , 1998, The Journal of Neuroscience.

[16]  Fritz Hohagen,et al.  Impact of Experimentally Induced Serotonin Deficiency by Tryptophan Depletion on Sleep EEG in Healthy Subjects , 1998, Neuropsychopharmacology.

[17]  Karl J. Friston,et al.  Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion , 1999, British Journal of Psychiatry.

[18]  R. Schiffmann,et al.  White matter lesions in Fabry disease occur in ‘prior’ selectively hypometabolic and hyperperfused brain regions , 2003, Brain Research Bulletin.

[19]  P. Cowen,et al.  Decreased plasma tryptophan levels in major depression. , 1989, Journal of affective disorders.

[20]  Ramin V Parsey,et al.  Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. , 2003, Archives of general psychiatry.

[21]  R. Maddock.  The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain , 1999, Trends in Neurosciences.

[22]  D. Charney,et al.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.

[23]  Matthew L. Ho,et al.  Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. , 2003, The American journal of psychiatry.

[24]  H. Meltzer,et al.  Effects of ipsapirone on plasma cortisol and body temperature in major depression , 1995, Biological Psychiatry.

[25]  G. Biggio,et al.  Effect of the oral administration of tryptophan‐free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism , 1974, Journal of neurochemistry.

[26]  M. Mintun,et al.  Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. , 1996, The American journal of psychiatry.

[27]  D. Murphy,et al.  Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.

[28]  M. Åsberg,et al.  "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.

[29]  M. Fava,et al.  Tryptophan depletion in SSRI-recovered depressed outpatients , 2001, Psychopharmacology.

[30]  S. Koslow,et al.  CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. , 1983, Archives of general psychiatry.

[31]  John J. B. Allen,et al.  Tryptophan depletion and depressive vulnerability , 1999, Biological Psychiatry.

[32]  Helen S Mayberg,et al.  Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. , 2002, The American journal of psychiatry.

[33]  B. Leonard,et al.  Monoamine transport in depression: kinetics and dynamics. , 1987, Journal of affective disorders.

[34]  Linda Carpenter,et al.  Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.

[35]  C. Benkelfat,et al.  Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. , 1994, Archives of general psychiatry.

[36]  KA Smith,et al.  Relapse of depression after rapid depletion of tryptophan , 1997, The Lancet.

[37]  M. Leboyer,et al.  Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder , 2001, Biological Psychiatry.

[38]  R. Salomon,et al.  Association of a Critical CSF Tryptophan Threshold Level with Depressive Relapse , 2003, Neuropsychopharmacology.

[39]  S. Kasper,et al.  Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. , 2002, Archives of general psychiatry.

[40]  G. Curzon.  Relationships between plasma, CSF and brain tryptophan. , 1979, Journal of neural transmission. Supplementum.

[41]  M. Sewitch,et al.  Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans , 2005, Psychopharmacology.

[42]  Karl J. Friston,et al.  Covariation of Activity in Habenula and Dorsal Raphé Nuclei Following Tryptophan Depletion , 1999, NeuroImage.

[43]  S. Watson,et al.  Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression , 1998, Biological Psychiatry.

[44]  T. Robbins,et al.  The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers , 2002, Psychopharmacology.

[45]  A. Leon,et al.  Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. , 1992, Archives of general psychiatry.

[46]  P F Liddle,et al.  Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study , 2001, British Journal of Psychiatry.

[47]  F. Bloom,et al.  The 5-HT3 Receptor Is Present in Different Subpopulations of GABAergic Neurons in the Rat Telencephalon , 1997, The Journal of Neuroscience.

[48]  W. Riedel,et al.  Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders , 1999, Biological Psychiatry.

[49]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[50]  Michael J. Anderle,et al.  The neural substrates of affective processing in depressed patients treated with venlafaxine. , 2003, The American journal of psychiatry.

[51]  A. Coppen,et al.  Total and free tryptophan concentration in the plasma of depressive patients. , 1973, Lancet.

[52]  Marcus E Raichle,et al.  Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels , 2002, Pharmacology Biochemistry and Behavior.

[53]  Eric Vermetten,et al.  Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. , 2003, JAMA.

[54]  P. Salkovskis,et al.  Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot study , 1995, Psychological Medicine.

[55]  J. Mann,et al.  Blunted Serotonergic Responsivity in Depressed Inpatients , 1995, Neuropsychopharmacology.

[56]  R. Gur,et al.  Mood effects on limbic blood flow correlate with emotional self-rating: A PET study with oxygen-15 labeled water , 1995, Psychiatry Research: Neuroimaging.

[57]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[58]  V. Knott,et al.  The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects , 1999, Biological Psychiatry.

[59]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[60]  D Hommer,et al.  Effects of Acute Tryptophan Depletion on Plasma and Cerebrospinal Fluid Tryptophan and 5‐Hydroxyindoleacetic Acid in Normal Volunteers , 1999, Journal of neurochemistry.